Stockreport

Seres shares drop 7% after news of FDA orphan drug designation for ulcerative colitis therapy [MarketWatch]

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Seres Therapeutics Inc. shares dropped 7.4% in premarket trade on Monday after the company said its microbiome therapy intended for ulcerative colitis received an orphan [Read more]